The customer obtained questionable high elecsys hcg + beta test system (hcg+b) results using the analytical e module (serial (b)(4)) for two female patients who were not pregnant.Of the data provided, the results for patient a were discrepant.The customer initially believed the results to be true positives due to possible tumors secreting hcg+b.The customer states that the hcg+b results "reduced over time" after treatment with methotrexate.All results are in units of miu/ml, and all were released outside the laboratory.No data flags or alarms occurred.Patient a: the initial sample was drawn (b)(6) 2017 and analyzed (b)(6) 2017.The initial result was 36; repeat results were 35 and 35.A second sample was drawn (b)(6) 2017 and analyzed (b)(6) 2017.The initial result was 37; repeat results were 38 and 38.The patient and physician had performed "spot" (random) urine pregnancy tests that were also positive.On an unspecified date, the patient underwent an ultrasound which was negative, and she was treated with methotrexate.The patient was not adversely affected.The customer requested investigational confirmation testing for the samples.No samples from patient a were received, and the clinician stated he did not require additional testing.A specific root cause could not be identified.Additional information for further investigation was requested but was not provided.
|